The changing face of prostate cancer: can gains in epigenetic knowledge translate into improvements in clinical care?

被引：2

作者：

Catto, J. W. F. ^{[1
]}

机构：

[1] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England

来源：

JOURNAL OF MOLECULAR MEDICINE-JMM | 2006年 / 84卷 / 11期

关键词：

D O I：

10.1007/s00109-006-0110-0

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：883 / 885

页数：3

共 18 条

[1] Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy [J].

Bastian, PJ ;

Palapattu, GS ;

Lin, XH ;

Yegnasubramanian, S ;

Mangold, LA ;

Trock, B ;

Eisenberger, MA ;

Partin, AW ;

Nelson, WG .

CLINICAL CANCER RESEARCH, 2005, 11 (11) :4037-4043

[2] Early stage prostate cancer - Do we have a problem with over-detection, overtreatment or both? [J].

Carroll, PR .

JOURNAL OF UROLOGY, 2005, 173 (04) :1061-1062

[3] Neuro-fuzzy modeling: An accurate and interpretable method for predicting bladder cancer progression [J].

Catto, JWF ;

Abbod, MF ;

Linkens, DA ;

Hamdy, FC .

JOURNAL OF UROLOGY, 2006, 175 (02) :474-479

[4] Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma [J].

Catto, JWF ;

Azzouzi, AR ;

Rehman, I ;

Feeley, KM ;

Cross, SS ;

Amira, N ;

Fromont, G ;

Sibony, M ;

Cussenot, O ;

Meuth, M ;

Hamdy, FC .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) :2903-2910

[5] The changing face of prostate cancer [J].

Cooperberg, MR ;

Moul, JW ;

Carroll, PR .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (32) :8146-8151

[6] Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma [J].

Dhawan, D. ;

Hamdy, F. C. ;

Rehman, I. ;

Patterson, J. ;

Cross, S. S. ;

Feeley, K. M. ;

Stephenson, Y. ;

Meuth, M. ;

Catto, J. W. F. .

JOURNAL OF PATHOLOGY, 2006, 209 (03) :336-343

[7] Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells [J].

Fronsdal, K ;

Saatcioglu, F .

PROSTATE, 2005, 62 (03) :299-306

[8] Molecular pathways to prostate cancer [J].

Gonzalgo, ML ;

Isaacs, WB .

JOURNAL OF UROLOGY, 2003, 170 (06) :2444-2452

[9] Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma [J].

Harden, SV ;

Guo, Z ;

Epstein, JI ;

Sidransky, D .

JOURNAL OF UROLOGY, 2003, 169 (03) :1138-1142

[10]

HENRIQUE R, 2006, IN PRESS J MOL MED, DOI DOI 10.1007/S109-006-0099-4

← 1 2 →